BONE BIOLOGICS CORPORATION

BBLGW ·Healthcare, Medical Devices, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
DEF 14A Aug 28, 2026 DEF 14A
PRE 14A Aug 18, 2026 PRE 14A
10-Q Aug 14, 2026 10-Q
EFFECT Jul 24, 2026
424B3 Jul 24, 2026 424B3
8-K Jul 23, 2026 8-K
DEFA14A Jul 20, 2026 DEFA14A
S-3 Jul 17, 2026 S-3
8-K Jul 16, 2026 8-K
8-K Jul 9, 2026 8-K
ARS Jul 2, 2026 ARS
DEFA14A Jul 2, 2026 DEFA14A
DEF 14A Jul 2, 2026 DEF 14A
10-Q May 14, 2026 10-Q
8-K Mar 13, 2026 8-K
424B5 Mar 13, 2026 424B5
10-K Mar 2, 2026 10-K
4 Jan 21, 2026 4
4 Jan 21, 2026 4
8-K Jan 8, 2026 8-K
10-Q Nov 14, 2025 10-Q
SCHEDULE 13G/A Nov 7, 2025
S-8 Sep 26, 2025 S-8
8-K Sep 4, 2025 8-K
EFFECT Sep 2, 2025
← Newer Page 1 of 20 · 477 filings Older →